Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference36 articles.
1. Infliximab, azathioprine, or combination therapy for Crohn’s disease;Colombel;N Engl J Med,2010
2. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis;Panaccione;Gastroenterology,2014
3. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: surgical management and special situations;Gionchetti;J Crohns Colitis,2016
4. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management;Harbord;J Crohns Colitis,2017
5. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease;Rahier;J Crohns Colitis,2014
Cited by 406 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States;Journal of Managed Care & Specialty Pharmacy;2024-02-03
2. Increasing ratio of opportunistic infections associated with sunshine exposure and economic level burdening Chinese inflammatory bowel disease hospitalized patients: the first nationwide survey from 2014 to 2019;BMC Public Health;2024-01-09
3. Comparative efficacy and tolerability of probiotic, prebiotic, and synbiotic formulations for adult patients with mild-moderate ulcerative colitis in an adjunctive therapy: A network meta-analysis;CLIN NUTR;2024
4. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01
5. Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea;Mycoses;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3